K-Bro Linen Inc

K-Bro Linen Inc. maintains a market price of 39.28 CAD, with a market capitalization of 510.27 million CAD. The company's price-to-earnings ratio is 28.36, and its price-to-book ratio is 1.86, indicating a moderate premium to its book value. The enterprise value to EBITDA ratio is 19.60, and the enterprise value to revenue ratio is 1.59, suggesting a relatively high valuation relative to its earnings and revenue. The company's profitability is reflected in a return on equity of 6.57% and a return on assets of 2.55%, both of which are below the industry median for Business Support Services. The gross profit margin is 79.3%, and the operating margin is 8.1%, indicating a strong gross margin but a moderate operating margin. The net income margin is 3.55%, which is in line with the industry average. K-Bro Linen Inc. operates in multiple geographic regions, with a significant presence in Canada and a smaller footprint in the United Kingdom. The company's revenue is concentrated in these two regions, with no disclosed segment breakdown. The company's operations are diversified across healthcare, hospitality, and manufacturing sectors, which helps mitigate sector-specific risks. The company's revenue growth trajectory is expected to remain stable, with no significant changes projected in the current fiscal year or the next fiscal year. The company's operating cash flow is 62.71 million CAD, and its free cash flow is 38.22 million CAD, indicating a strong ability to generate cash from operations. The capital expenditure is -15.36 million CAD, suggesting a reduction in capital spending. The company's liquidity risk is rated as medium, with a current ratio of 1.88, indicating a reasonable ability to meet short-term obligations. The debt-to-equity ratio is 1.17, and the long-term debt is 320.37 million CAD, which is a significant portion of the company's total liabilities. The dilution risk is rated as low, with no near-term pressure expected. Recent events and filings indicate that the company has not issued any new shares in the past year, and there are no upcoming share offerings or dilutive events disclosed. The company's financial health is supported by its strong operating cash flow and moderate debt levels, which provide flexibility for future growth and operational needs.